526445 — Indrayani Biotech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹2.81bn
- IN₹3.72bn
- IN₹1.66bn
- 10
- 33
- 31
- 10
Annual balance sheet for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 6.79 | 15 | 127 | 303 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 78.5 | 154 | 323 | 464 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 96.2 | 189 | 775 | 1,450 |
| Net Property, Plant And Equipment | 253 | 259 | 479 | 594 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 401 | 514 | 1,560 | 2,350 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 118 | 195 | 719 | 871 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 203 | 272 | 1,009 | 1,678 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 197 | 242 | 551 | 672 |
| Total Liabilities & Shareholders' Equity | 401 | 514 | 1,560 | 2,350 |
| Total Common Shares Outstanding |